PositiveID to Unveil Its Iglucose System for Diabetes Management During Diabetes Awareness Month and Make Major Announcement and Update On FDA Status

Iglucose Connects Patients, Caregivers, Physicians and Insurance Companies to Coordinate Care, Help Improve Outcomes and Decrease Costs to Our Healthcare System

--()--Media Advisory: Invitation to Press Conference

WHO:  

PositiveID Corporation

CEO Bill Caragol
VP Marketing and Business Development Mary Ellen Harrison
 
WHAT: PositiveID Corporation, a local company, will unveil its wireless iglucose system for diabetes management. The Company will demo the iglucose system for all who attend, including the device, website and real-time text messaging platform. PositiveID will also make a major announcement about the system and provide an update on its FDA status.
 
WHEN: Wednesday, November 16, 2011, at 11:00 am ET
 
WHERE: PositiveID Headquarters, Delray Beach, FL
1690 S. Congress Ave., Suite 200
Delray Beach, FL 33445
 
WHY: Diabetes is an epidemic in our country. More than 25 million people in the U.S. have diabetes. A cornerstone of diabetes management is testing blood sugar levels with a blood glucose meter. The value proposition of iglucose is to seamlessly communicate glucose readings from blood glucose meters to the iglucose diabetes management portal, where this important data can be shared in real time with family members, caregivers and healthcare professionals via text message, email or fax. This makes it possible to improve care in a cost-effective manner and stay in touch with loved ones, providing peace of mind and accurate data to help improve outcomes.
 
November is also Diabetes Awareness Month. This is an ideal time to bring this important information to viewers and readers in our communities.
 
VISUALS: Photo and video opportunities will include executive interviews and live demonstrations of the product.

Contacts

PositiveID Corporation
Allison Tomek, 561-805-8044
atomek@positiveidcorp.com